- Home
- DRRX vs LRE Comparison
DRRX vs LRE Comparison
Compare DRRX & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRRX
- LRE
- Stock Information
- Founded
- DRRX 1998
- LRE 2001
- Country
- DRRX United States
- LRE Japan
- Employees
- DRRX N/A
- LRE N/A
- Industry
- DRRX Biotechnology: Pharmaceutical Preparations
- LRE
- Sector
- DRRX Health Care
- LRE
- Exchange
- DRRX Nasdaq
- LRE Nasdaq
- Market Cap
- DRRX 26.3M
- LRE 22.5M
- IPO Year
- DRRX 2000
- LRE 2023
- Fundamental
- Price
- DRRX $0.80
- LRE $1.35
- Analyst Decision
- DRRX Buy
- LRE
- Analyst Count
- DRRX 2
- LRE 0
- Target Price
- DRRX $5.00
- LRE N/A
- AVG Volume (30 Days)
- DRRX 54.3K
- LRE 5.3K
- Earning Date
- DRRX 03-26-2025
- LRE 01-01-0001
- Dividend Yield
- DRRX N/A
- LRE N/A
- EPS Growth
- DRRX N/A
- LRE N/A
- EPS
- DRRX N/A
- LRE 0.29
- Revenue
- DRRX $8,594,000.00
- LRE $117,804,154.00
- Revenue This Year
- DRRX $54.32
- LRE N/A
- Revenue Next Year
- DRRX N/A
- LRE N/A
- P/E Ratio
- DRRX N/A
- LRE $4.61
- Revenue Growth
- DRRX N/A
- LRE 8.82
- 52 Week Low
- DRRX $0.70
- LRE $1.19
- 52 Week High
- DRRX $1.88
- LRE $13.76
- Technical
- Relative Strength Index (RSI)
- DRRX 49.63
- LRE 30.61
- Support Level
- DRRX $0.73
- LRE $1.20
- Resistance Level
- DRRX $0.83
- LRE $1.70
- Average True Range (ATR)
- DRRX 0.05
- LRE 0.10
- MACD
- DRRX 0.01
- LRE -0.02
- Stochastic Oscillator
- DRRX 63.57
- LRE 25.89
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.